Pricing
Login
Home
Charts
Search
Watchlist
Products

Anlon Healthcare Ltd

AHCL
₹25.17+0.80%20 Nov 2026
Reports
Pharma API

Anlon Healthcare Ltd

AHCL
₹25.17
+0.80%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,338Cr
Close
Close Price
₹25.17
Industry
Industry
Pharma API
PE
Price To Earnings
30.70
PS
Price To Sales
4.78
Revenue
Revenue
₹280Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
493352365188106
Growth YoY
Revenue Growth YoY%
4.0162.9102.3
Expenses
ExpensesCr
32273823367280
Operating Profit
Operating ProfitCr
1761412151625
OPM
OPM%
35.118.826.334.530.117.823.9
Other Income
Other IncomeCr
0000000
Interest Expense
Interest ExpenseCr
1112111
Depreciation
DepreciationCr
1000011
PBT
PBTCr
1551211141423
Tax
TaxCr
-1135356
PAT
PATCr
1749511817
Growth YoY
PAT Growth YoY%
-33.5133.284.3
NPM
NPM%
34.010.717.914.521.89.516.3
EPS
EPS₹
5.20.90.00.10.20.20.3
QuarterMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
493352365188106
Growth YoY
Revenue Growth YoY%
4.0162.9102.3
Expenses
ExpensesCr
32273823367280
Operating Profit
Operating ProfitCr
1761412151625
OPM
OPM%
35.118.826.334.530.117.823.9
Other Income
Other IncomeCr
0000000
Interest Expense
Interest ExpenseCr
1112111
Depreciation
DepreciationCr
1000011
PBT
PBTCr
1551211141423
Tax
TaxCr
-1135356
PAT
PATCr
1749511817
Growth YoY
PAT Growth YoY%
-33.5133.284.3
NPM
NPM%
34.010.717.914.521.89.516.3
EPS
EPS₹
5.20.90.00.10.20.20.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
120172280
Growth
Revenue Growth%
43.0
Expenses
ExpensesCr
88124211
Operating Profit
Operating ProfitCr
324868
OPM
OPM%
26.827.624.5
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
444
Depreciation
DepreciationCr
223
PBT
PBTCr
274362
Tax
TaxCr
61321
PAT
PATCr
212942
Growth
PAT Growth%
41.8
NPM
NPM%
17.116.914.9
EPS
EPS₹
6.40.60.8
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
120172280
Growth
Revenue Growth%
43.0
Expenses
ExpensesCr
88124211
Operating Profit
Operating ProfitCr
324868
OPM
OPM%
26.827.624.5
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
444
Depreciation
DepreciationCr
223
PBT
PBTCr
274362
Tax
TaxCr
61321
PAT
PATCr
212942
Growth
PAT Growth%
41.8
NPM
NPM%
17.116.914.9
EPS
EPS₹
6.40.60.8
Sales CAGR
1 Year43%
3 Years-
5 Years-
TTM-
EBITDA CAGR
1 Year48%
3 Years-
5 Years-
TTM-
PAT CAGR
1 Year42%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year17%
3 Years-
5 Years-
TTM20%
CFO / EBITDA
1 Year-124%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
4053106
Reserves
ReservesCr
41177151
Current Liabilities
Current LiabilitiesCr
60108145
Non Current Liabilities
Non Current LiabilitiesCr
411212
Total Liabilities
Total LiabilitiesCr
181374453
Current Assets
Current AssetsCr
158308369
Non Current Assets
Non Current AssetsCr
236684
Total Assets
Total AssetsCr
181374453
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
4053106
Reserves
ReservesCr
41177151
Current Liabilities
Current LiabilitiesCr
60108145
Non Current Liabilities
Non Current LiabilitiesCr
411212
Total Liabilities
Total LiabilitiesCr
181374453
Current Assets
Current AssetsCr
158308369
Non Current Assets
Non Current AssetsCr
236684
Total Assets
Total AssetsCr
181374453

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-22-59
Investing Cash Flow
Investing Cash FlowCr
3-36
Financing Cash Flow
Financing Cash FlowCr
19118
Net Cash Flow
Net Cash FlowCr
023
Free Cash Flow
Free Cash FlowCr
-19-95
CFO To PAT
CFO To PAT%
-106.7-202.5
CFO To EBITDA
CFO To EBITDA%
-68.0-124.0
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-22-59
Investing Cash Flow
Investing Cash FlowCr
3-36
Financing Cash Flow
Financing Cash FlowCr
19118
Net Cash Flow
Net Cash FlowCr
023
Free Cash Flow
Free Cash FlowCr
-19-95
CFO To PAT
CFO To PAT%
-106.7-202.5
CFO To EBITDA
CFO To EBITDA%
-68.0-124.0

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5921,338
Price To Earnings
Price To Earnings
20.830.7
Price To Sales
Price To Sales
3.44.8
Price To Book
Price To Book
2.65.2
EV To EBITDA
EV To EBITDA
13.320.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.034.134.1
OPM
OPM%
26.827.624.5
NPM
NPM%
17.116.914.9
ROCE
ROCE%
20.816.920.0
ROE
ROE%
25.512.616.2
ROA
ROA%
11.37.89.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5921,338
Price To Earnings
Price To Earnings
20.830.7
Price To Sales
Price To Sales
3.44.8
Price To Book
Price To Book
2.65.2
EV To EBITDA
EV To EBITDA
13.320.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.034.134.1
OPM
OPM%
26.827.624.5
NPM
NPM%
17.116.914.9
ROCE
ROCE%
20.816.920.0
ROE
ROE%
25.512.616.2
ROA
ROA%
11.37.89.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,4324,4223,0501,3381,313795627
Close PriceClose₹473.25484.50628.2525.17446.1579.28179.37
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE37.3819.3482.0230.7025.0216.6211.13
Price To SalesPS4.561.551.994.782.561.020.93
RevenueRevenueCr9712,8511,535280513778676
Revenue Growth TTMRev Gr TTM%13.0%15.1%27.3%-8.8%6.6%7.5%
PAT Growth TTMPAT Gr TTM%28.3%14.9%476.3%-55.3%23.4%4.8%
Market CapitalizationMkt CapCr4,4324,4223,0501,3381,313795627
Close PriceClose₹473.25484.50628.2525.17446.1579.28179.37
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE37.3819.3482.0230.7025.0216.6211.13
Price To SalesPS4.561.551.994.782.561.020.93
RevenueRevenueCr9712,8511,535280513778676
Revenue Growth TTMRev Gr TTM%13.0%15.1%27.3%-8.8%6.6%7.5%
PAT Growth TTMPAT Gr TTM%28.3%14.9%476.3%-55.3%23.4%4.8%